HomeAbout usHospitalsSearchLogin
Your medical data, safe and secure.
Name
FG-4592
Description
FibroGen completed the phase I single-dose, dose escalation studies as of July 2007. Multiple dose, dose escalation and phase II US studies are listed as ongoing.
No brand information found.
